Stay updated on IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now includes a detailed Locations section with state-specific sites (CA, GA, KY, MO, NJ, PA, SC, TN, UT, VT) and a revision note indicating v3.3.3. The HHS Vulnerability Disclosure link and references to v3.3.2 were removed.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe Publications note was updated to indicate auto-fill from PubMed and that items may not be about the study; the revision tag was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe site-wide funding-status banner was removed from the Study Details page, and the core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedNo substantive changes to the study record are evident between the screenshots, and the page structure remains the same—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check89 days agoChange DetectedUpdates include a new status notice about government funding and NIH Clinical Center operations (critical core content) and a new version tag v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check96 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.